FDA warning letter
Issue date
30 Sept 2021
Issuing office
Division of Pharmaceutical Quality Operations III
Posted date
19 Oct 2021
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Marcus Research Laboratory
Manufacturer
Warning letter
Headquarters
United States of AmericaSites
United States of America